Study of rolapitant, a novel, long-acting, NK-1 receptor antagonist, for the prevention of chemotherapy-induced nausea and vomiting (CINV) due to highly emetogenic chemotherapy (HEC)
出版年份 2015 全文链接
标题
Study of rolapitant, a novel, long-acting, NK-1 receptor antagonist, for the prevention of chemotherapy-induced nausea and vomiting (CINV) due to highly emetogenic chemotherapy (HEC)
作者
关键词
Rolapitant, NK-1 receptor antagonist, Antiemetic, Chemotherapy-induced nausea and vomiting (CINV)
出版物
SUPPORTIVE CARE IN CANCER
Volume 23, Issue 11, Pages 3281-3288
出版商
Springer Nature
发表日期
2015-05-04
DOI
10.1007/s00520-015-2738-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study
- (2014) P. J. Hesketh et al. ANNALS OF ONCOLOGY
- A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy
- (2014) R. J. Gralla et al. ANNALS OF ONCOLOGY
- A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy
- (2014) M. Aapro et al. ANNALS OF ONCOLOGY
- Incidence of infusion-site reactions associated with peripheral intravenous administration of fosaprepitant
- (2014) Jordan D. Lundberg et al. SUPPORTIVE CARE IN CANCER
- Professional educational needs for chemotherapy-induced nausea and vomiting (CINV): multinational survey results from 2,388 health care providers
- (2014) Emily S. Van Laar et al. SUPPORTIVE CARE IN CANCER
- An analysis of fosaprepitant-induced venous toxicity in patients receiving highly emetogenic chemotherapy
- (2014) Livia T. Hegerova et al. SUPPORTIVE CARE IN CANCER
- Management of Chemotherapy-Induced Nausea and Vomiting
- (2013) Rudolph M. Navari DRUGS
- Molecular mechanisms of 5-HT3 and NK1 receptor antagonists in prevention of emesis
- (2013) Camilo Rojas et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Prognostic factors for chemotherapy induced nausea and vomiting
- (2013) David Warr EUROPEAN JOURNAL OF PHARMACOLOGY
- Evaluation of Risk Factors Predicting Chemotherapy-Related Nausea and Vomiting: Results From a European Prospective Observational Study
- (2013) Alexander Molassiotis et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Effect of netupitant, a highly selective NK1 receptor antagonist, on the pharmacokinetics of midazolam, erythromycin, and dexamethasone
- (2013) Corinna Lanzarotti et al. SUPPORTIVE CARE IN CANCER
- Safety, efficacy, and patient acceptability of single-dose fosaprepitant regimen for the prevention of chemotherapy-induced nausea and vomiting
- (2013) Luigi Celio et al. Patient Preference and Adherence
- The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)
- (2012) M. Aapro et al. ANNALS OF ONCOLOGY
- Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
- (2012) H. Saito et al. ANNALS OF ONCOLOGY
- Pharmacological mechanisms of 5-HT3 and tachykinin NK1 receptor antagonism to prevent chemotherapy-induced nausea and vomiting
- (2012) Camilo Rojas et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2011) Ethan Basch et al. JOURNAL OF CLINICAL ONCOLOGY
- Update and new trends in antiemetic therapy: the continuing need for novel therapies
- (2010) P. Feyer et al. ANNALS OF ONCOLOGY
- Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
- (2010) F. Roila et al. ANNALS OF ONCOLOGY
- Aprepitant: drug-drug interactions in perspective
- (2010) M. S. Aapro et al. ANNALS OF ONCOLOGY
- Pharmacokinetic evaluation of fosaprepitant dimeglumine
- (2010) Francheska Colon-Gonzalez et al. Expert Opinion on Drug Metabolism & Toxicology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started